Demant A/S (OTCMKTS:WILYY) Sees Unusually-High Trading Volume - Here's Why

Key Points

• Low ADR liquidity: Mid-day trading saw just 400 shares change hands and the stock last traded at $17.12, up from the prior close of $16.60.
• Analyst upgrade: Jefferies raised Demant to a "strong-buy" on March 18, and the consensus rating is currently "Buy" (two Strong Buy, one Hold).
• Company and fundamentals: Demant is a Denmark-based hearing-healthcare group (brands include Oticon, Bernafon, Sonic, and Oticon Medical); its 50-day/200-day moving averages are $14.31/$16.09 and its debt-to-equity, quick and current ratios are 1.65, 1.00 and 1.36 respectively.

Shares of Demant A/S Unsponsored ADR (OTCMKTS:WILYY - Get Free Report) saw an uptick in trading volume on Tuesday . 400 shares changed hands during mid-day trading, a decline of 8% from the previous session's volume of 433 shares.The stock last traded at $17.12 and had previously closed at $16.60.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group raised shares of Demant A/S from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, March 18th. Two investment analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Buy".

Demant A/S Price Performance

The business's 50-day moving average is $14.31 and its 200-day moving average is $16.09. The company has a debt-to-equity ratio of 1.65, a quick ratio of 1.00 and a current ratio of 1.36.

Demant A/S Company Profile

Demant A/S is a Denmark-based global hearing health care company specializing in the development, manufacture and distribution of hearing solutions and audiological diagnostic instruments. The company's flagship brands include Oticon, Bernafon and Sonic, which offer a range of hearing aids designed to address various levels of hearing loss. In addition to personal hearing devices, Demant provides diagnostic equipment such as audiometers and tympanometers, supporting hearing care professionals in accurate assessment and fitting of hearing solutions.

Beyond hearing aids and diagnostics, Demant's product portfolio extends to hearing implants—cochlear and bone-anchored systems—through its Oticon Medical division.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.